Regarding PD, the mitigation of glial activation and neurodegeneration in an animal model of the disease by C/EBPβ knock down has been recently described by our group [30], suggesting that this transcription factor could be a good therapeutic target for this disease. The gene discussed is CEBPB; the disease is Parkinson disease.